FREMONT, Calif., July 30, 2024 /PRNewswire/ -- Alamar Biosciences,
a company powering precision proteomics to enable the earliest
detection of disease, is excited to announce the opening of its
European headquarters and distribution center in Milan, Italy. This strategic expansion marks a
significant milestone in Alamar Biosciences' commitment to
advancing global scientific research through high-sensitivity
biomarker solutions and supporting the commercialization of its
ARGO™ HT System and NULISA™ Platform.
The new European headquarters will serve as the central hub for
Alamar Biosciences' operations across Europe, enhancing the company's ability to
provide innovative products and exceptional customer service to its
growing base of European clients. The distribution center in
Milan will ensure efficient and
timely delivery of Alamar's comprehensive range of proteomics
products, reinforcing the company's dedication to meeting the
evolving needs of the global research community.
"We are thrilled to announce the opening of our European
headquarters and distribution center in Milan," said Yuling
Luo, Ph.D., Chairman, Founder and CEO of
Alamar. "This strategic expansion reflects our ongoing
commitment to supporting the scientific community across
Europe. Milan's dynamic environment and strategic
location will allow us to better serve our customers and accelerate
the delivery of our innovative solutions."
Key Highlights of the Expansion:
- Enhanced Customer Service: The establishment of the
European headquarters will enable Alamar Biosciences to offer
localized support, faster response times, and personalized services
to its European customers.
- Improved Distribution Efficiency: The new distribution
center will streamline logistics, ensuring that Alamar's products
reach customers across Europe more
swiftly and reliably.
- Commitment to Growth: This expansion underscores Alamar
Biosciences' commitment to growth and innovation in the
biotechnology sector, as well as its dedication to improving global
healthcare outcomes.
- Strategic Location: Milan, known for its robust infrastructure and
central location, offers an ideal location for Alamar Biosciences
to strengthen its presence in Europe.
"Supporting our European research clients in a timely and
efficient manner is essential to Alamar's global success," stated
Luigi Pirovano, Managing Director,
Alamar Biosciences Europe, srl. "Our logistical expertise,
strategic location, and extensive experience in the life sciences
sector will further enhance the entire customer experience with
Alamar's products and services."
About Alamar Biosciences, Inc.
Alamar Biosciences is a privately held life sciences company
with a mission to power precision proteomics to enable the earliest
detection of disease. The company's proprietary NULISA Platform
along with the ARGO™ HT System work seamlessly with the latest
advances in genomics to achieve single digit attomolar detection
sensitivity, greatly surpassing the most sensitive protein
detection technology on the market today. For more information,
please visit alamarbio.com.
Video - https://www.youtube.com/watch?v=kMO4MgPNCYw
Video - https://www.youtube.com/watch?v=9KcTXmAWCdc
Logo -
https://mma.prnewswire.com/media/1810182/4835130/Alamar_Logo_WhiteOutline_RGB_4x1_Logo_V1.jpg
View original
content:https://www.prnewswire.co.uk/news-releases/alamar-biosciences-establishes-european-headquarters-and-distribution-center-in-milan-italy-302209365.html